|
Volumn 4, Issue 6, 1999, Pages 585-592
|
Present and potential future use of gene therapy for the treatment of non-insulin dependent diabetes mellitus (Review).
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLUCAGON;
GLUCAGON LIKE PEPTIDE 1;
GLUCOKINASE;
GLUCOSE TRANSPORTER;
GLUCOSE TRANSPORTER 2;
HOMEODOMAIN PROTEIN;
INSULIN;
INSULIN PROMOTER FACTOR 1;
LECTIN;
NEURONAL NITRIC OXIDE SYNTHASE;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NOS1 PROTEIN, HUMAN;
NOS1 PROTEIN, MOUSE;
NOS1 PROTEIN, RAT;
PANCREATITIS ASSOCIATED PROTEIN;
PANCREATITIS-ASSOCIATED PROTEIN;
PAP PROTEIN, MOUSE;
PEPTIDE FRAGMENT;
PROTEIN;
PROTEIN PRECURSOR;
SYNTHETIC DNA;
TRANSACTIVATOR PROTEIN;
TUMOR ANTIGEN;
TUMOR MARKER;
ADULT;
ANIMAL;
CELL TRANSPLANTATION;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENE VECTOR;
GENETICS;
GLUCOSE BLOOD LEVEL;
HUMAN;
HYPERINSULINISM;
INSULIN RESISTANCE;
MIDDLE AGED;
MOUSE;
MUSCLE CONTRACTION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET;
PANCREAS ISLET TRANSPLANTATION;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROMOTER REGION;
RAT;
REVIEW;
SECRETION;
ADULT;
ANIMALS;
ANTIGENS, NEOPLASM;
BLOOD GLUCOSE;
CELL TRANSPLANTATION;
DIABETES MELLITUS, TYPE 2;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENES, SYNTHETIC;
GENETIC VECTORS;
GLUCAGON;
GLUCAGON-LIKE PEPTIDE 1;
GLUCOKINASE;
GLUCOSE TRANSPORTER TYPE 2;
HOMEODOMAIN PROTEINS;
HUMANS;
HYPERINSULINISM;
HYPOGLYCEMIC AGENTS;
INSULIN;
INSULIN RESISTANCE;
ISLETS OF LANGERHANS;
ISLETS OF LANGERHANS TRANSPLANTATION;
LECTINS, C-TYPE;
MICE;
MIDDLE AGED;
MONOSACCHARIDE TRANSPORT PROTEINS;
MUSCLE CONTRACTION;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
NITRIC OXIDE SYNTHASE TYPE I;
PEPTIDE FRAGMENTS;
PROMOTER REGIONS (GENETICS);
PROTEIN PRECURSORS;
PROTEINS;
RATS;
TRANS-ACTIVATORS;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
EID: 0033257769
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.4.6.585 Document Type: Review |
Times cited : (4)
|
References (62)
|